Asset Management One’s Lifecore Biomedical LFCR Stock Holding History

Asset Management One’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-34,100	Closed	-$457K	–	1110
2016 Q3	$457K	Sell	34,100 -2,400	-7%	-$29.1K	0.01%	1059
2016 Q2	$393K	Sell	36,500 -19,400	-35%	-$214K	0.01%	1106
2016 Q1	$587K	Sell	55,900 -2,900	-5%	-$31.9K	0.01%	1032
2015 Q4	$696K	Sell	58,800 -2,200	-4%	-$27K	0.01%	985
2015 Q3	$712K	Buy	61,000 +6,700	+12%	+$88.8K	0.01%	957
2015 Q2	$784K	Hold	54,300	–	–	0.01%	961
2015 Q1	$757K	Buy	54,300 +3,900	+8%	+$53.9K	0.01%	983
2014 Q4	$696K	Sell	50,400 -4,100	-8%	-$53K	0.01%	956
2014 Q3	$668K	Buy	54,500 +4,600	+9%	+$57.4K	0.01%	943
2014 Q2	$623K	Buy	49,900 +14,000	+39%	+$165K	0.01%	899
2014 Q1	$401K	Buy	35,900 +23,100	+180%	+$253K	0.01%	963
2013 Q4	$155K	Buy	+12,800	New	+$153K	﹤0.01%	1073

Other funds holding LFCR

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Asset Management One's LFCR Position: Q4 2016 in Review

Asset Management One sold out of Lifecore Biomedical (LFCR) in Q4 2016, closing a stake of 34,100 shares — an estimated $457K sold.

Asset Management One first reported a position in LFCR in Q4 2013 and held it in 12 quarters. The position peaked at $784K in Q2 2015. 93 funds tracked by Wall St. Rank hold LFCR as of Q4 2016.

Asset Management One reported no remaining Lifecore Biomedical position as of Q4 2016 after selling out during the quarter.
Asset Management One sold 34,100 Lifecore Biomedical shares in Q4 2016, an estimated $457K.
Asset Management One first reported a position in Lifecore Biomedical in Q4 2013 and held it in 12 quarters.
Asset Management One's Lifecore Biomedical position peaked at $784K in Q2 2015.
93 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.